Larisma, Rosalie C.
HRN: 29-06-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2026
MUPIROCIN 2%, 15G (TUBE)
05/30/2026
06/05/2026
TOPICAL
2%
BID
Ulcer
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines